Growing community of inventors

Brookline, MA, United States of America

Jaebong Jang

Average Co-Inventor Count = 4.81

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

Jaebong JangNathanael Schiander Gray (14 patents)Jaebong JangPasi Antero Janne (13 patents)Jaebong JangMichael Eck (7 patents)Jaebong JangHwan Geun Choi (6 patents)Jaebong JangDries De Clercq (5 patents)Jaebong JangDavid A Scott (3 patents)Jaebong JangJohn M Hatcher (2 patents)Jaebong JangKwok-kin Wong (2 patents)Jaebong JangAlyssa Verano (2 patents)Jaebong JangJamie A Saxon (2 patents)Jaebong JangNathanael S Gray (1 patent)Jaebong JangCiric To (1 patent)Jaebong JangDavid Heppner (1 patent)Jaebong JangJieun Son (1 patent)Jaebong JangDries De Clercq (1 patent)Jaebong JangKwok-Kin Wong (1 patent)Jaebong JangEunyoung Park (1 patent)Jaebong JangHwanguen Choi (0 patent)Jaebong JangJaebong Jang (14 patents)Nathanael Schiander GrayNathanael Schiander Gray (173 patents)Pasi Antero JannePasi Antero Janne (32 patents)Michael EckMichael Eck (10 patents)Hwan Geun ChoiHwan Geun Choi (51 patents)Dries De ClercqDries De Clercq (5 patents)David A ScottDavid A Scott (14 patents)John M HatcherJohn M Hatcher (19 patents)Kwok-kin WongKwok-kin Wong (17 patents)Alyssa VeranoAlyssa Verano (6 patents)Jamie A SaxonJamie A Saxon (2 patents)Nathanael S GrayNathanael S Gray (17 patents)Ciric ToCiric To (3 patents)David HeppnerDavid Heppner (3 patents)Jieun SonJieun Son (1 patent)Dries De ClercqDries De Clercq (1 patent)Kwok-Kin WongKwok-Kin Wong (2 patents)Eunyoung ParkEunyoung Park (1 patent)Hwanguen ChoiHwanguen Choi (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Dana-Farber-Cancer Institute Inc. (14 from 1,210 patents)


14 patents:

1. 12331037 - Pyrimidines as EGFR-inhibitors and methods of treating disorders

2. 12161649 - Inhibitors of EGFR and methods of use thereof

3. 11945816 - Inhibitors of EGFR and/or HER2 and methods of use

4. 11814379 - Cyano quinoline amide compounds as HER2 inhibitors and methods of use

5. 11673882 - Pyrimidines as EGFR inhibitors and methods of treating disorders

6. 11584746 - Inhibitors of EGFR and methods of use thereof

7. 11186574 - Inhibitors of EGFR and/or HER2 and methods of use

8. 11161842 - Bifunctional molecules for degradation of EGFR and methods of use

9. 10870636 - Pyrimidines as EGFR inhibitors and methods of treating disorders

10. 10836722 - Inhibitors of EGFR and methods of use thereof

11. 10550112 - Pyrimidines as EGFR inhibitors and methods of treating disorders

12. 10450310 - Bifunctional molecules for degradation of EGFR and methods of use

13. 10385019 - Inhibitors of EGFR and methods of use thereof

14. 10266517 - Pyrimidines as EGFR inhibitors and methods of treating disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…